Virkningen af plasmaferese på natalizumab- clearance og - farmakodynamik er evalueret i et forsøg med 12 MS- patienter.
The effect of plasma exchange on natalizumab clearance and pharmacodynamics was evaluated in a study of 12 MS patients.